Structure Therapeutics (GPCR) Amortizatization of Intangibles (2023 - 2026)
Structure Therapeutics (GPCR) posted quarterly Amortizatization of Intangibles of $10000.0 for Q1 2026, down 96.89% quarter-over-quarter from $322000.0 in Q4 2025.
Analysis
Structure Therapeutics (GPCR) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Structure Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $10000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to $10000.0; the TTM figure through Mar 2026 stood at $342000.0 (changed N/A YoY), while the FY2025 annual figure was $345000.0, up 8525.0% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $10000.0, down from $322000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $322000.0 in Q4 2025, with the low at -$7000.0 in Q4 2024.
- The 4-year median for Amortizatization of Intangibles is $13500.0 (2023), against an average of $85500.0.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles plunged 141.18% in 2024, then surged 4700.0% in 2025.
- Structure Therapeutics' Amortizatization of Intangibles stood at $17000.0 in 2023, then sank by 141.18% to -$7000.0 in 2024, then soared by 4700.0% to $322000.0 in 2025, then slumped by 96.89% to $10000.0 in 2026.
- Business Quant data shows GPCR's Amortizatization of Intangibles at $10000.0 in Q1 2026, $322000.0 in Q4 2025, and -$7000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Structure Therapeutics | 10.32 Bn | 10.32 Bn | - | 19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 322,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 17,000.00 |